
IndraLab
Statements
sparser
"A similar approach might be applied to VEGF-A whose high expression is associated with poor prognosis [ xref ]: in fact, we showed that in colorectal [ xref ] and gastric [ xref ] cancers hERG1 expression is significantly associated with VEGF-A expression and the combined therapy with bevacizumab and hERG1 blockers impairs tumor growth in mouse models [ xref ]."